Trial ID or NCT#

NCT01728116

Status

RECRUITING

Purpose

To determine if the EndoBarrier safely and effectively improves glycemic control in obese subjects with type 2 diabetes

Official Title

A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Comparing the EndoBarrier Gastrointestinal Liner System vs. Sham for Glycemic Improvement in Inadequately Controlled Obese Type 2 Diabetic Subjects on Oral Anti-Diabetes Agents

Eligibility Criteria

Ages Eligible for Study: 21 Years to 65 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Tracey McLaughlin
Endocrinologist
Professor of Medicine (Endocrinology) at the Stanford University Medical Center
Dr. John Magaña Morton
Bariatric surgeon, General surgeon, Minimally invasive surgeon
Associate Professor of Surgery (General Surgery) at the Stanford University Medical Center
Marilyn Tan, MD
Endocrinologist
Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism

Contact us to find out if this trial is right for you.

CONTACT

Elizabeth Colbert
(650) 723-3186